COMUNICADO: COUR Pharmaceuticals, Boehringer Ingelheim, Genentech, GSK, Idorsia Pharmaceuticals: Veeva Commercial Summit

- COUR Pharmaceuticals, Boehringer Ingelheim, Genentech, GSK, e Idorsia Pharmaceuticals serán ponentes en Veeva Commercial Summit, Europa.

COMUNICADO: COUR Pharmaceuticals, Boehringer Ingelheim, Genentech, GSK, Idorsia Pharmaceuticals: Veeva Commercial Summit

- COUR Pharmaceuticals, Boehringer Ingelheim, Genentech, GSK, e Idorsia Pharmaceuticals serán ponentes en Veeva Commercial Summit, Europa

More than 1,000 innovators in sales, medicine and marketing come together to share strategies for the future of digital engagement in the life sciences

BARCELONA, Spain, Nov. 15, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that leaders from COUR Pharmaceuticals, Boehringer Ingelheim, Genentech, GSK and Idorsia Pharmaceuticals will be keynote speakers at the 2022 Veeva Commercial Summit , Europe, which will take place from November 28 to 30, 2022 in Madrid. Global life sciences professionals will come together to share how the industry is advancing the digital engagement of high-value healthcare professionals (HCPs) and explore the changing role of data, content and engagement in the improving omnichannel customer journeys.

The keynote address will be delivered by Malcolm Crooks, COO of COUR Pharmaceuticals. "As our industry shifts its focus to specialty medications that require precision engagement with healthcare professionals, accelerating digital excellence is an imperative for all," Crooks said. "Forward-thinking business teams that use software and data strategically also ensure continued efficiency gains amid economic pressures."

Leaders from major biopharmaceuticals will headline the event's 100+ sessions on sales, medical and marketing trends, including:

"Changes in the omnichannel experience, customer intelligence and analytics have paved the way for more meaningful HCP participation," said Chris Moore, president of Veeva Europe. "It is an honor to bring together so many biopharmaceutical visionaries from our customer community to reconnect and brainstorm how they are advancing their business strategies."

At the event, Veeva will share the European findings from its latest Veeva Pulse Field Trends Report, the industry's most comprehensive benchmark of HCP engagement from more than 80% of commercial biopharma field teams worldwide. .

Veeva Commercial Summit is one of the largest gatherings of life sciences business leaders in Europe. The three-day conference invites sales, medical and marketing teams to brainstorm and connect with their peers. The theme of this year's event highlights how digital excellence helps companies improve customer engagement in the life sciences. Professionals in the life sciences sector can register here.

Additional Information Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems Follow @veeva_eu on Twitter: twitter.com/veeva_eu

About Veeva Systems

Veeva is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world's largest pharmaceutical companies to emerging biotech companies. As a public benefit corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

ContactoJeremy WhittakerVeeva Systems 49-695-095-5486jeremy.whittaker@veeva.com

logo - link

View original content: enlace

Yorum yapabilmek için üye girişi yapmanız gerekmektedir.

Üye değilseniz hemen üye olun veya giriş yapın.

NEXT NEWS